This week on Contemporary OB/GYN®: August 16 to August 20

Article

Here's what to look for this week on Contemporary OB/GYN®.

You can expect a variety of topics this week, including:

FDA accepts pembrolizumab as singlea agent for treatment of advanded endometrial cancer

New biomarker could predict immunotherapy benefit in breast cancer

New Hampshire's abortion restrictions

Oral contraceptives and risk of cardiac events in women with congenital long-QT syndrome

The impact of nutrition on gynecological diseases

Recent Videos
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
New cervical cancer screening guidelines: What practitioners needs to know | Image Credit: forhers.com
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.